Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Radiother Oncol ; 40(1): 23-30, 1996 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8844884

RESUMEN

BACKGROUND AND PURPOSE: The erythematous response of human skin to radiotherapy has proven useful for testing the predictions of the linear quadratic (LQ) model in terms of fractionation sensitivity and repair half time. No formal investigation of the response of human skin to doses less than 2 Gy per fraction has occurred. This study aims to test the validity of the LQ model for human skin at doses ranging from 0.4 to 5.2 Gy per fraction. MATERIALS AND METHODS: Complete erythema reaction profiles were obtained using reflectance spectrophotometry in two patient populations: 65 patients treated palliatively with 5, 10, 12 and 20 daily treatment fractions (varying thicknesses of bolus, various body sites) and 52 patients undergoing prostatic irradiation for localised carcinoma of the prostate (no bolus, 30-32 fractions). RESULTS AND CONCLUSIONS: Gender, age, site and prior sun exposure influence pre- and post-treatment erythema values independently of dose administered. Out-of-field effects were also noted. The linear quadratic model significantly underpredicted peak erythema values at doses less than 1.5 Gy per fraction. This suggests that either the conventional linear quadratic model does not apply for low doses per fraction in human skin or that erythema is not exclusively initiated by radiation damage to the basal layer. The data are potentially explained by an induced repair model.


Asunto(s)
Eritema/etiología , Radiodermatitis/epidemiología , Radioterapia de Alta Energía/efectos adversos , Piel/efectos de la radiación , Anciano , Relación Dosis-Respuesta en la Radiación , Femenino , Folículo Piloso/efectos de la radiación , Humanos , Modelos Lineales , Masculino , Persona de Mediana Edad , Cuidados Paliativos , Neoplasias de la Próstata/tratamiento farmacológico , Tolerancia a Radiación , Radiodermatitis/diagnóstico , Radiodermatitis/etiología , Dosificación Radioterapéutica , Factores de Riesgo , Espectrofotometría/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA